{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":17,"n_cols":5,"rows_kept":17,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[10,2,10,3],[11,2,11,3],[14,2,14,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910483635403321"]
[null,null,"Titolo",null,"Advances in psoriasis : a multisystemic guide / / Jeffrey M. Weinberg, Mark Lebwohl"]
[null,null,"Pubbl/distr/stampa",null,"Cham, Switzerland : , : Springer, , [2021]"]
[{"$nulls":4},"©2021"]
[null,null,"ISBN",null,"3-030-54859-7"]
[null,null,"Edizione",null,"[2nd ed. 2021.]"]
[null,null,"Descrizione fisica",null,"1 online resource (VI, 423 p. 54 illus., 45 illus. in color.)"]
[null,null,"Disciplina",null,"616.526"]
[null,null,"Soggetti",null,"Psoriasis - Treatment"]
[{"$nulls":4},"Psoriasis"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Includes index."]
[null,null,"Nota di contenuto",null,"Introduction to and History of Psoriasis and Psoriasis Therapy -- Pathophysiology of Psoriasis/Novel Pathways -- Psoriasis: Clinical Review and Update -- Psoriasis: Epidemiology, Potential Triggers, Disease Course -- Topical Therapy I: Corticosteroids and Vitamin D Analogues -- Topical Therapy II: Retinoids, Immunomodulators, and Others -- Topical Therapy II: Retinoids, Immunomuodulators, and Others/ Ultraviolet Therapy for Psoriasis -- Laser Therapy for Psoriasis -- Traditional Systemic Therapy I: Methotrexate and Cyclosporine -- Traditional Systemic Therapy II: Retinoids and Others -- Apremilast -- Etanercept -- Adalimumab -- Infliximab, Golimumab , and Certolizumab Pegol -- Ustekinumab -- Guselkumab -- Tidrakizumab -- Risankizumab -- Secukinumab -- Ixekizumab -- Brodalumab -- Biosimilars for Psoriasis -- Research Pipeline I: Oral Therapeutics for Psoriasis -- Research Pipeline II: Upcoming Biologic Therapies -- Pediatric Psoriasis -- Challenges in Psoriasis Treatment: Nail, Scalp, and Palmoplantar Involvement -- Psoriasis and Comorbidities -- Summary of Published Treatment Guidelines -- Index."]
[null,null,null,"Sommario/riassunto","This extensively revised second edition provides an up-to-date and highly informative textbook on psoriasis. The understanding of the mechanisms behind the disease and the available treatment options have continued to develop rapidly in recent times, with this vital resource covering the latest in these management options, including targeted T-cell therapy, the use of immunomodulators, systemic therapies, and ultraviolet and laser therapy. In addition, it provides a "]
[{"$nulls":4},"detailed overview of the pathophysiology, comorbidities, epidemiology and triggers of the disease. Advances in Psoriasis: A Multisystemic Guide extensively details the scientific basis and practice management of psoriasis. It is therefore a vital resource for practicing and trainee dermatologists looking to develop their clinical knowledge of how to manage and treat these patients."]